Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12178-017-9413-8 http://scihub22266oqcxt.onion/10.1007/s12178-017-9413-8 C5435644!5435644 !28324328     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28324328 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Curr+Rev+Musculoskelet+Med 2017 ; 10 (2 ): 182-188 Nephropedia Template TP {{tp|p=28324328 |t=2017. Interspinous implants to treat spinal stenosis |pdf=|usr=}}{{28324328 }} gab.com Text Interspinous implants to treat spinal stenosis JO: Curr Rev Musculoskelet Med http://www.kidney.de/pget.php?&tw=1&pmid=28324328 #FOAvip PURPOSE OF REVIEW: Lumbar spinal stenosis has historically been treated with open decompressive surgery which is associated with significant morbidity and may give rise to various complications. Interspinous spacers (ISS) have been developed as a less invasive strategy which may serve to avoid many of these risks. The two current spacers that are FDA approved and commercially available are the Coflex and Superion devices. The goal is to review these two implants, their indications, and patient selection. RECENT FINDINGS: The Coflex device has been shown to be analogous to decompression and fusion when treating moderate spinal stenosis. It provides dynamic stability after a decompression is performed, without the rigidity of pedicle-screw instrumentation. Recent results show improved outcomes in Coflex patients at 3 years of follow-up, as compared to decompression and fusion. The Superion implant is placed percutaneously in the interspinous space with minimal disruption of spinal anatomy. When compared to the X-Stop device (which is no longer available), the Superion implant shows improved outcomes at 3 years of follow-up. ISS are lesser invasive options as compared to formal decompression and fusion for the treatment of lumbar spinal stenosis. Twit Text FOAVip Interspinous implants to treat spinal stenosis ????Curr Rev Musculoskelet Med http://www.kidney.de/pget.php?&tw=1&pmid=28324328 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28324328 #FOAvip English Wikipedia <ref>{{Cite pmid|28324328 }}</ref> Interspinous implants to treat spinal stenosis #MMPMID28324328 Gala RJ ; Russo GS ; Whang PG Curr Rev Musculoskelet Med 2017[Jun]; 10 (2 ): 182-188 PMID28324328 show ga PURPOSE OF REVIEW: Lumbar spinal stenosis has historically been treated with open decompressive surgery which is associated with significant morbidity and may give rise to various complications. Interspinous spacers (ISS) have been developed as a less invasive strategy which may serve to avoid many of these risks. The two current spacers that are FDA approved and commercially available are the Coflex and Superion devices. The goal is to review these two implants, their indications, and patient selection. RECENT FINDINGS: The Coflex device has been shown to be analogous to decompression and fusion when treating moderate spinal stenosis. It provides dynamic stability after a decompression is performed, without the rigidity of pedicle-screw instrumentation. Recent results show improved outcomes in Coflex patients at 3 years of follow-up, as compared to decompression and fusion. The Superion implant is placed percutaneously in the interspinous space with minimal disruption of spinal anatomy. When compared to the X-Stop device (which is no longer available), the Superion implant shows improved outcomes at 3 years of follow-up. ISS are lesser invasive options as compared to formal decompression and fusion for the treatment of lumbar spinal stenosis. äInterspinous implants to treat spinal stenosis (epmc).pdf DeepDyve Pubget Overpricing